Wegovy® for weight loss prescription online

Wegovy® is an under-the-skin, self-administered injectable prescription medicine for patients with either:

• A body mass index (BMI) of 30 kg/m2 or greater

• A BMI of 27 kg/m2 or greater with at least one weight-related ailment such as type 2 diabetes, hypertension, sleep apnea, or others.

Choosing the proper weight loss treatment for you is a personal decision between you and your doctor. It’s also important to see your doctor regularly during treatment. Our convenient monthly telemedicine appointments help patients meet their health goals with expert, professional medical support. In today’s busy world, we bring world-class medicine right to you.

Wegovy® is a medication for chronic weight management used with diet and exercise. When used in conjunction with lifestyle changes, this weight loss drug can be effective in helping patients lose excess weight. It comes as a pen-injector in a range of doses starting at 0.25 mg and topping out at 2.4 mg.

Weight loss

Obesity is a chronic health issue that requires long-term management and is associated with severe health complications, including heart disease, diabetes, sleep apnea, asthma, hormonal concerns for women such as PCOS, arthritis, and certain types of cancer. Losing five to ten percent of body weight can bring impactful health benefits, such as:

• Reduced risk of heart disease

• Improved energy

• Improved blood pressure, blood sugar, and cholesterol levels

On June 4, 2021, the U.S. Food and Drug Administration (FDA) approved Wegovy® for adults who suffer from obesity or are overweight. This is the first drug for chronic weight management that has been approved since 2014.

Combined with a reduced-calorie meal plan and increased physical activity, Wegovy® can be highly effective in helping patients lose weight.

Dedicated to providing individualized solutions, we recognize Wegovy®  as an outstanding choice; however, we aim to highlight alternatives for patients seeking the most suitable treatment for weight management. Our physicians may recommend or prescribe other GLP-1 options depending on availability and individual preferences. Explore these choices:

• Semaglutide: Due to shortages, compounded semaglutide may be prescribed as an alternative to branded Wegovy® as long as it remains on the FDA drug shortages list. Although compounded semaglutide is not FDA-approved, our pharmacy provider complies with pertinent federal and state laws and FDA regulations.*

• Zepbound® (tirzepatide): A breakthrough in weight management, this dual-action GLP-1 and GIP receptor agonist not only aids in regulating blood sugar levels, but also presents a promising avenue for effective weight loss.

Other medications our doctors may prescribe for weight loss include:

• Xenical® (orlistat): This medication blocks dietary fat breakdown and absorption by the body.

• Contrave® (naltrexone/bupropion): This is a once-daily tablet that promotes weight loss by helping promote feelings of fullness.

*As of 1/4/2024, availability for compounded semaglutide is currently limited to residents in the following states: AZ, CA, CO, DC, DE, FL, GA, HI, IA, ID, IL, KS, MA, MD, ME, MO, MT, ND, NE, NH, NM, NV, NY, OH, OK, OR, PA, RI, TN, TX, UT, WA, WY. Although compounded semaglutide is not FDA-approved, our pharmacy provider complies with all federal and state laws and FDA regulations. Doses of Wegovy® that are in shortage will be available as compounded semaglutide only until the shortage has ended.

Risk reduction of cardiovascular events 

Now, Wegovy® isn't just for weight loss; it also can protect against life-threatening cardiovascular events. Recently approved by the FDA in March 2024, Wegovy® is the first weight loss medication to offer this dual benefit.  Heart disease, heart attacks, and strokes are all-too-common risks associated with obesity and being overweight. This FDA-approved medication not only helps you shed excess weight but also can significantly reduce your risk of these potentially deadly cardiovascular events.(4) In a rigorous trial involving over 17,600 participants, Wegovy® significantly reduced the risk of major adverse cardiovascular events, including cardiovascular death, heart attack, and stroke.(4)  Other medications prescribed to lower the risk of life-threatening cardiovascular events include: 

• Statins such as Zocor (simvastatin), Lipitor (atorvastatin), and rosuvastatin (Crestor), which lower cholesterol levels 

• ACE inhibitors like Capoten (captopril), Altace (ramipril), Lotensin (benazepril), Accupril (quinapril), Lotrel (amlodipine & benazepril), and Vasotec (enalapril), which help relax blood vessels and lower blood pressure 

Consult with one of our doctors to learn about the best option for your cardiovascular health. 

Nausea

Diarrhea

Constipation

Vomiting

Abdominal pain

Headache

Fatigue

If you experience any severe side effects such as serious allergic reactions, a severe rash, rapid heartbeat, or severe pain, seek emergency medical help immediately.